MedTrace Logo

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

NCT03194347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-12-12

No results posted yet for this study

Summary

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the knowledge of a molecular-genetic finding affects the therapeutic decision of the physician. Furthermore, genetic changes in the tumor tissue will be compared with the changes in CTCs, DTCs and cfDNA.

Conditions

  • Gynecologic Cancer

Interventions

DIAGNOSTIC_TEST

molecular genetic analyses

molecular genetic analyses

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Andreas D Hartkopf, Prof · Department of Women's Health

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-29
Primary Completion
2020-05-29
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03194347 on ClinicalTrials.gov